FDA Drug Safety Concerns & Foreign Manufacturing
Lawmakers urge FDA scrutiny of foreign drugmakers after ProPublica investigation. Concerns over safety & quality failures. Focus on domestic production & supply chain risks highlighted.
FDA’s Foreign Drug Oversight: Safety Concerns & Exemptions Exposed
ProPublica investigation reveals FDA's oversight lapses on foreign drugmakers, raising concerns about unsafe medications entering the U.S. via exemptions. Legislators demand answers on drug safety and accountability.
FDA Exemptions: Concerns over Drug Quality and Safety
ProPublica reports on FDA exemptions allowing banned foreign factories to ship drugs to the U.S., raising concerns about drug quality, patient safety, and regulatory oversight. Focus on FDA and sunlight pharma.
FDA Cuts Jeopardize Drug Safety: ProPublica Investigation
FDA staff cuts impacting crucial international drug factory inspections, potentially jeopardizing the safety of medications used by millions. ProPublica reveals safety concerns and staff depletion.
FDA’s Secret Drug Loophole: Banned Factories Supply US
ProPublica reveals FDA's loophole allowing over 150 drugs from banned factories with mold/filth to enter the US, raising safety concerns and potential patient harm.